FDA Inspection 770117 — HCSC-Blood Center

HCSC-Blood Center — FEI 2573135

The FDA completed an inspection of HCSC-Blood Center on Mar 1, 2012 in Bethlehem, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 1, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Bethlehem, PA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.